Anvendelsen af hormonelle kombinationspræventionsmidler, inklusive EVRA, medfører en øget risiko for venøs tromboemboli (dyb venøs trombose, lungeemboli) sammenlignet med ingen anvendelse.
The use of any combined hormonal contraceptive, including EVRA, carries an increased risk of venous thromboembolism (deep vein thrombosis, pulmonary embolism) compared to no use.